NCT00557661View on ClinicalTrials.gov

Safety Study of CD-NP in Heart Failure

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2007

Study Completion Date

December 31, 2008

Conditions

Congestive Heart Failure

Interventions

DRUG

CD-NP

24 hr intravenous infusion

Sponsors

Lead Sponsor

Nile Therapeutics

All Listed Sponsors

lead

Nile Therapeutics

INDUSTRY

NCT00557661 - Safety Study of CD-NP in Heart Failure | Biotech Hunter | Biotech Hunter